Cargando…
Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
SIMPLE SUMMARY: This commentary focuses on the methods currently available to test the efficacy and safety of new orally inhaled drugs for the treatment of uncurable respiratory diseases, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or lung cancer, prior to entering human ex...
Autores principales: | Movia, Dania, Prina-Mello, Adriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460012/ https://www.ncbi.nlm.nih.gov/pubmed/32722259 http://dx.doi.org/10.3390/ani10081259 |
Ejemplares similares
-
In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
por: Movia, Dania, et al.
Publicado: (2020) -
Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials
por: Tutty, Melissa Anne, et al.
Publicado: (2022) -
Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs
por: Movia, Dania, et al.
Publicado: (2018) -
The Case for Modernizing Biomedical Research in Ireland through the Creation of an Irish 3Rs Centre
por: Galligioni, Viola, et al.
Publicado: (2022) -
Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook
por: Prina-Mello, Adriele, et al.
Publicado: (2021)